Are you Dr. Tsui?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-5735Fax+1 206-520-5620
Summary
- Dr. Judith Tsui, MD is a board certified internist in Seattle, Washington. She is currently licensed to practice medicine in Washington, Massachusetts, and California. She is affiliated with UW Medicine/Harborview Medical Center and is an Assistant Professor at Boston University School of Medicine.
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
- New York University School of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 2004 - Present
- OR State Medical License 1999 - Present
- WA State Medical License 2014 - 2025
- MA State Medical License 2008 - 2015
- GA State Medical License 2000 - 2005
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Clinical Trials
- Trial of Adherence App for Buprenorphine Treatment (TAAB) Study Start of enrollment: 2019 Feb 15
Publications & Presentations
PubMed
- 245 citationsBuprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical TrialJane M. Liebschutz, Denise Crooks, Debra S. Herman, Bradley J. Anderson, Judith I. Tsui
JAMA Internal Medicine. 2014-08-01 - 35 citationsThe Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis.Richard A Jenkins, Bridget M Whitney, Robin M Nance, Todd M Allen, Hannah L F Cooper
Addiction Science & Clinical Practice. 2022-07-26 - 7 citationsOptimal hepatitis C treatment adherence patterns and sustained virologic response among people who inject drugs: The HERO study.Moonseong Heo, Brianna L Norton, Irene Pericot-Valverde, Shruti H Mehta, Judith I Tsui
Journal of Hepatology. 2024-05-01
Authored Content
- Receipt of Alcohol-Related Care Among Patients with HCV and Unhealthy Alcohol UseMay 2018
Press Mentions
- Hepatitis C Reinfection Rates Drop for Drug Users over TimeNovember 7th, 2024
- Study Finds Video DOT Could Increase Access to Methadone Treatment and Reduce RiskOctober 13th, 2022
- App Did Not Improve Adherence in Opioid Addiction ProgramAugust 19th, 2021
- Join now to see all
Grant Support
- HCV And Pain In Substance Users With And Without HIVNational Institute On Drug Abuse2010–2011